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Long chain acyl-CoA synthetase (ACSL) catalyzes the initial step
in long chain fatty acid metabolism. Of the five mammalian ACSL
isoforms cloned and characterized, ACSL5 is the only isoform
found to be located, in part, on mitochondria and thus was hypoth-
esized to be involved in fatty acid oxidation. To elucidate the spe-
cific roles of ACSL5 in fatty acid metabolism, we used adenoviral-
mediated overexpression of ACSL5 (Ad-ACSL5) in rat hepatoma
McArdle-RH7777 cells. Confocal microscopy revealed that
Ad-ACSL5 colocalized to both mitochondria and endoplasmic
reticulum. When compared with cells infected with Ad-GFP,
Ad-ACSL5-infected cells at 24 h after infection had 2-fold higher
acyl-CoA synthetase activities and 30% higher rates of fatty acid
uptake when incubated with 500 M [1-14C]oleic acid. Metabolism
of [1-14C]oleic acid to cellular triacylglycerol (TAG) increased 42%
in Ad-ACSL5-infected cells, but when compared with control cells,
metabolism to acid-soluble metabolites, phospholipids, and
medium TAG did not differ substantially. The incorporation of
[1-14C]oleate and [1,2,3-3H]glycerol into TAG was similar in
Ad-ACSL5-infected cells, thus indicating that Ad-ACSL5 increased
TAG synthesis through both de novo and reacylation pathways.
However, [1-14C]acetic acid incorporation into cellular lipids
showed that, when compared with control cells, Ad-ACSL5-in-
fected cells did not increase the metabolism of fatty acids that were
derived from de novo synthesis. These results suggest that uptake of
fatty acids into cells is regulated by metabolism and that overex-
pressed ACSL5 partitions exogenously derived fatty acids toward
TAG synthesis and storage.
Acyl-CoA synthetase catalyzes the initial step in mammalian fatty
acid metabolism. In this reaction, fatty acid, CoA, and ATP are used to
form acyl-CoA and AMP. Acyl-CoAs have diverse metabolic fates
within the cell and can be used to acylate proteins or be metabolized
through catabolic pathways such as -oxidation or anabolic pathways
such as de novo synthesis and reacylation of triacylglycerol (TAG),2
phospholipids, and cholesterol esters.
To date, five isoforms of long chain acyl-CoA synthetase have been
cloned and shown to possess activity toward long chain fatty acids. The
unique pattern of tissue expression, subcellular localization, and differ-
ences in substrate preference among the isoforms suggests that individ-
ual isoforms have distinct functions. ACSL1,ACSL4, andACSL5 appear
to be the predominant isoforms in rat liver (1–5). ACSL1 andACSL4 are
located in liver endoplasmic reticulum and mitochondrial-associated
membrane (6), an endoplasmic reticulum fraction possibly involved in
lipoprotein synthesis (7). In addition, ACSL4 is also present on peroxi-
somes and has a marked preference for C20:4 and C20:5 (2). ACSL5 is
the only isoform found in both mitochondrial membranes and endo-
plasmic reticulum (6) and, similar to ACSL1, has its highest preference
for saturated and unsaturated fatty acids of 16–20 carbons (1).
Because ACSL5 is the only ACSL isoform known to be located on
mitochondria, it is logical to speculate that it has a role in the -oxida-
tion of fatty acids. In support of this hypothesis, rat liver mitochondrial
protein content of ACSL5 increases following a 48-h fast but declines
when rats are refed a high sucrose diet for 24 h (6). To date, the most
direct studies that focus on ACSL used triacsin C, an inhibitor of
ACSL1, ACSL3, and ACSL4 but not ACSL5 or ACSL6 (8, 9). In hepa-
tocytes obtained from fed rats, triacsin C decreases [1-14C]oleic acid
incorporation into TAG by 70% (10). In contrast, triacsin C decreases
the metabolism of [1-14C]oleic acid to phospholipids by 34% and to
ASM by 33%. Therefore, inhibiting ACSL1, ACSL3, and ACSL4
decreases fatty acid incorporation into TAG more than into phospho-
lipids or into pathways of fatty acid oxidation. Because hepatocytes
express little ACSL6 (4), ACSL5 could account for the triacsin C-resist-
ant activity in hepatocytes and might activate fatty acids destined for
-oxidation.
Despite its putative role in fatty acid oxidation, several lines of evi-
dence do not support a catabolic role for ACSL5. Tissue expression of
ACSL5 mRNA is highest in intestinal mucosa (1) and brown adipose
tissue (11). Although brown adipose tissue is characterized by high lev-
els of fatty acid oxidation and thermogenesis, both intestinal mucosa
and brown adipose tissue have a high capacity for TAG synthesis (12,
13). Additionally, regulation of ACSL5mRNAdoes not support a role in
fatty acid -oxidation. Hepatic ACSL5 message abundance does not
change in response to peroxisomal proliferator-activated receptor 
agonists (14) but increases nearly 4-fold in SREBP-1c transgenic mice
and is reduced 40% in SREBP cleavage-activating protein knock-out
mice (15). Administration of leptin to C57BL/6J obese ob/ob mice
causes a 1.5-fold decrease in ACSL5 mRNA expression together with
down-regulation of lipogenic genes and increased expression of numer-
ous oxidative genes (16). In addition, hepatic ACSL5 message level
increases 1.6-fold in zinc-deficient mice with fatty livers (17) and
decreases 1.5-fold in estrogen-related receptor knock-out mice, which
exhibit a reduction in lipogenic gene expression and reduced total body
fat (18). Taken together, there are many discrepancies in the literature
between regulation of ACSL5 mRNA and protein abundance and the
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effects of triacsin C on fatty acid channeling. Therefore, our goal was to
use a direct approach to elucidate the function of ACSL5. We ectopi-
cally overexpressed ACSL5 in rat hepatoma McArdle-RH7777 cells to
determine its role in fatty acid activation and partitioning.
EXPERIMENTAL PROCEDURES
Materials—Silica gel G plates were from Whatman. [1-14C]Oleic
acid, [1,2,3-3H]glycerol, and [1-14C]acetic acid were from PerkinElmer
Life Sciences. Tissue culture dishes were fromCorning, andmedia were
obtained from Invitrogen. All chemicals were from Sigma unless other-
wise indicated.
Construction of Recombinant GFP and ACSL5-FLAG Adenovirus—
ACSL5 cDNA was cloned from rat liver total RNA and amplified using
primers designed to include the entire open reading frame (8). The
amplification productwas ligated into the pET-FLAGvector containing
a T7 promoter and a C-terminal FLAG epitope sequence (DYKD-
DDDK) to form pET-ACSL5F. A 2091-bp construct was amplified from
the pET-ACSL5F vector, including the initiator AUG codon, the entire
ACSL5 coding region, a 24-bp FLAGepitope sequence at the 3 end, and
the TGA stop codon. The PCR product was digested with XhoI and
XbaI and ligated into the 9.2-kb pAdTrack-CMV shuttle vector
between the cytomegalovirus promoter and the polyadenylation site.
This vector contains a GFP gene driven by a second cytomegalovirus
promoter, which allows direct observation of the efficiency of infection
by fluorescence microscopy. The pAdTrack/ACSL5F construct was
sequenced at theUniversity of North Carolina (UNC)DNASequencing
Facility. The UNCVector Core Laboratory produced recombinant ade-
novirus (Ad-ACSL5) by homologous recombination of the shuttle vec-
tor and the pAdEasy-1 adenoviral plasmid (19). An identical pAdTrack-
CMV shuttle vector without the ACSL5 insert was used to produce a
recombinant adenovirus (Ad-GFP) for control infections.
McArdle-RH7777 Cell Culture and Adenoviral Infection—McArdle-
RH7777 cells were maintained in Dulbecco’s modified Eagle’s medium
containing 25 mM glucose, 10% fetal bovine serum, 10% horse serum,
plus 100 units/ml penicillin and 100 g/ml streptomycin on collagen-
coated dishes. Cells were trypsinized the day before adenoviral infec-
tion, and 1.2  106 cells were plated per 6-cm dish. Cells at 60–80%
confluence were infected with 10 multiplicity of infection of either Ad-
GFP or Ad-ACSL5. After 2 h, the media were changed.
Cell Radiolabeling, Lipid Extraction, and Measurement of Radioac-
tive Lipid Products and Fatty AcidUptake Assays—Radiolabelingmedia
contained 1.0 Ci of [1-14C]oleic acid bound to bovine serum albumin
in a 3:1molar ratio. The concentration of oleic acid inmediawas 20, 100,
or 500 M. In some experiments, 250 M [1,2,3-3H]glycerol or 2.5 mM
[1-14C]acetic acid was used. Additionally, 10 M triacsin C in Me2SO
was added to the radiolabeling media in some experiments to inhibit
ACSL1, ACSL3, and ACSL4. Untreated cells were incubated with the
same volume ofMe2SO (0.2% of themedium). Radiolabeledmedia were
added 24 h after adenoviral infection. After 3 h, aliquots of the radiola-
belingmedia were removed and used tomeasure ASMor extracted (20)
to measure radiolabel incorporation into media lipids. Residual radiola-
bel was removed by washing the cells once with PBS containing 1%
bovine serum albumin at 37 °C. Cellular lipids were extracted (20) and
separated on silica gel G plates in hexane:ethyl ether:acetic acid (80:20:1;
v/v). Known standards (Avanti) were used to identify lipids that were
then visualized by iodine vapor. The Bioscan 200 system was used to
quantify radiolabeled lipids. Initial rates of fatty acid uptake were meas-
ured as described (21) except that 35-mm culture dishes were used and
the radiolabeling medium contained 3.0 Ci of [1-14C]oleic acid.
Cell Homogenate Preparations for ACSL Activity and Protein Assays—
McArdle-RH7777 cells were washed with PBS, scraped in cold Medium I
(250 mM sucrose, 10 mM Tris, pH 7.4, 1 mM EDTA, 1 mM dithiothreitol),
and homogenized on ice with 10 up-and-down strokes in a Teflon glass
motor-driven homogenizing vessel, and aliquots were stored at 80 °C.
Acyl-CoAsynthetaseactivitywasmeasured in thepresenceof175mMTris,
pH7.4, 8mMMgCl2, 5mMdithiothreitol, 10mMATP, 250MCoA, and50
M [1-14C]palmitic acid (22).Only initial ratesweremeasured. Proteinwas
measured by the BCAmethod (Pierce).
Immunocytochemistry—McArdle-RH7777 cells were plated on
8-well chamber slides (Nunc) and infectedwithAd-ACSL5 as described
above. After 24 h, cells were washed in PBS and fixed with 3% paraform-
aldehyde for 20min at room temperature. Following several PBSwashes
at room temperature, cells were permeabilized with buffer A (10 g/l
digitonin, 300mM sucrose, 2.5mMMgCl2, 100mMKCl, 1mMEDTA, 10
mM PIPES, pH 6.8) for 30 min on ice. Cells were then incubated with
1.5% goat serum containing a 1/500 dilution of mouse anti-FLAG M2
monoclonal antibody (Sigma), 1/125 dilution of rabbit anti-VDAC,
1/500 dilution of rabbit anti-Grp78, or a combination of anti-FLAG
with the organelle markers for 1 h at room temperature. Following
several PBSwashes, cells were incubated in 1.5% goat serum anti-mouse
Alexa Fluor 633 or anti-rabbit Alexa Fluor 546 (Molecular Probes) for
1 h at room temperature in the dark. After washing with PBS, Gel/
Mount (Biomedia) was added to the cells, and coverslips were applied.
Confocal microscopy was performed on an Olympus FV500 laser scan-
ning microscope. TRITC and CY5 filters were used to visualize the
Alexa Fluor 546 and 633, respectively. Image J software (National Insti-
tutes of Health) was used for image analysis.
Quantitative Real-time-PCR—Livers from Sprague-Dawley rats
(130 g) were homogenized with a rotor stator homogenizer, and RNA
was isolated with the RNeasy kit (Qiagen). Forward and reverse prim-
ers for rat ACSL5 were 5-GGCCAAACAGAATGCACAG-3 and
5-GGAGTCCCAACATGACCTG-3. The FAMprobe corresponding
to the ACSL5 amplicon was 5-TGTCCAGTCCCCAGGTGATG-
TAAT-3. The rat -actin forward primer was 5-TGCCTGACGGT-
CAGGTCA-3, and the reverse primer was 5-CAGGAAGGAAG-
GCTGGAAG-3. The probe corresponding to the -actin amplicon
was 5-CACTATCGGCAATGAGCGGTTCCG-3. Samples were ana-
lyzed on an ABI Prism 7700 sequence detection system (Applied Bio-
systems). Data were analyzed using the relative standard curve method
as described in User Bulletin Number 2 in the product manual.
Statistics—Data were analyzed by Student’s t test, and significance
was declared at p  0.05.
RESULTS
Ad-ACSL5 Increases Total and Triacsin C-resistant Activity—To
determine the function of ACSL5, we infectedMcArdle-RH7777 cells, a
rat hepatoma cell line, with an adenoviral construct containing FLAG-
tagged ACSL5 and GFP. Infection efficiency monitored by fluorescent
microscopy was close to 100% for most infections and was always
greater than 90%. Ad-ACSL5 infection of McArdle-RH7777 cells
increased total ACSL activity 2-fold when compared with Ad-GFP-
infected cells (Fig. 1A). Since ACSL5 is only one of five known ACSL
isoforms involved in long chain fatty acid activation, we used triacsin C,
an inhibitor of ACSL1, ACSL3, and ACSL4, to better gauge the increase
in activity due to ACSL5 overexpression. In the presence of 20 M
triacsin C, ACSL activity in Ad-ACSL5-infected cells was 17-fold higher
than the Ad-GFP-infected controls. Previous quantitative real-time-
PCR analysis revealed that ACSL6, the only other known ACSL not
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inhibited by triacsin C, is not expressed inMcArdle-RH7777 cells. If we
assume that ACSL5 is solely responsible for the triacsin C-resistant
activity, it accounts for 6% of total ACSL activity in Ad-GFP-infected
cells and 40% in Ad-ACSL5-infected cells.
ACSL5Colocalizes withMitochondria andEndoplasmic Reticulum—
Our previous studies that used cell fractionation techniques have shown
that ACSL5 is present in both microsomes and mitochondria in rat
hepatocytes (6). We employed confocal microscopy to identify the sub-
cellular location of FLAG-tagged Ad-ACSL5 in McArdle-RH7777 cells
(Fig. 1B). The FLAG localization pattern showed substantial colocaliza-
tion with the anti-Grp78 antibody, an endoplasmic reticulum marker.
Similarly, FLAG also colocalized with the anti-VDAC antibody, a mito-
chondria marker. Immunofluorescence did not show the FLAGmarker
on the cell surface or the nuclear membrane. Therefore, overexpression
of FLAG-taggedACLS5 followed a localization pattern similar to that of
endogenous ACSL5.
Ad-ACSL5 Increases Fatty Acid Uptake and Partitioning to Cellular
TAG—Todetermine the effects of Ad-ACSL5 on fatty acidmetabolism,
we incubated McArdle-RH7777 cells with 20, 100, or 500 M oleic acid
for 3 h and measured [1-14C]oleic acid incorporation into cellular and
medium lipids and oxidation products. When compared with Ad-GFP-
infected controls, Ad-ACSL5 did not affect total oleic acid metabolism,
as measured by incorporation into cell lipids and medium TAG and
ASM, at 20 or 100 M but increased metabolism 28% at 500 M oleic
acid (Fig. 2A), a physiological concentration during short term fasts or a
preprandial state (23, 24). To verify these results, we measured initial
rates of fatty acid uptake (Fig. 1C). In close agreementwith the increased
fatty acid metabolism, we observed a 30% increase in rates of fatty acid
uptake when cells were incubated with 500 M oleic acid.
Cellular TAG represents the predominant storage form of exogenous
fatty acids in most cell types. Incorporation of [1-14C]oleic acid into
cellular TAG increased 22 and 21% at 20 and 100 M oleic acid, respec-
tively, in both Ad-GFP- and Ad-ACSL5-infected cells (Fig. 2B). How-
ever, with 500 M oleic acid in the medium, 42%more [1-14C]oleic acid
was incorporated in TAG in the Ad-ACSL5-infected cells when com-
pared with control cells. Similar to cell TAG, medium TAG increased
with increasing oleic acid concentrations in the media, but there were
no differences between Ad-GFP- and Ad-ACSL5-infected cells at any
fatty acid concentration (Fig. 2C). Although with 500 M oleic acid,
Ad-ACSL5 significantly increased [1-14C]oleic acid incorporation into
medium ASM (Fig. 2D), an indicator of ketone body production, the
13% increase is minor when compared with the increases in fatty acid
uptake and partitioning toTAG, thus disproving our original hypothesis
that ACSL5 activates fatty acids destined for -oxidation. There were
no differences in incorporation of [1-14C]oleic acid into cellular phos-
pholipids, fatty acids, or cholesterol esters, but Ad-ACSL5 increased
[1-14C]oleic acid incorporation into cellular DAG 2-fold when com-
pared with Ad-GFP-infected cells (Fig. 3A).
To further substantiate the role of ACSL5 in TAG synthesis, we incu-
bated cells with triacsin C, an inhibitor of ACSL1, ACSL3, and ACSL4,
but not ACSL5. Previous data in hepatocytes and fibroblasts showed
that triacsin c inhibits TAG synthesis more than ASM production (10,
25). In Ad-GFP-treated cells, triacsin C decreased TAG and ASM syn-
thesis similarly (Fig. 3B). However, Ad-ACSL5 infection blocked triac-
sin C-mediated inhibition of TAG synthesis and attenuated ASM
synthesis. Therefore, when other ACSL isoforms are inhibited, overex-
pressed ACSL5 can fully compensate for impaired TAG synthesis but
can only partially restore ASM production.
Ad-ACSL5 Increases TAGSynthesis through Both deNovo andReacy-
lation Pathways—With the changes in partitioning of fatty acids, we
consideredwhether the increase of oleic acid incorporation into cellular
TAG in Ad-ACSL5-infected cells was due to de novo synthesis or to
reacylation pathways. We labeled cells with 250 M [1,2,3-3H]glycerol
plus 500 M [1-14C]oleic acid to elucidate the mechanism of enhanced
TAG synthesis. Ad-ACSL5-infected cells incorporated 35% more
[14C]oleic acid and 28% more [3H]glycerol into cellular TAG relative to
Ad-GFP controls (Fig. 4A). The ratio of [14C]oleic acid to [3H]glycerol
incorporation was also similar between Ad-GFP (4.6) and Ad-ACSL5
(4.8) groups. In phospholipids, [1-14C]oleic acid incorporation did not
differ between treatment groups, but [1,2,3-3H]glycerol incorporation
into phospholipids was suppressed 22% in theAd-ACSL5-infected cells.
This led to an increase in the [14C]oleic acid to [3H]glycerol ratio (3.1 for
Ad-GFP versus 3.8 for Ad-ACSL5), suggesting that overexpression of
ACSL5 suppresses de novo phospholipid synthesis more than
reacylation.
FIGURE 1. Ad-ACSL5 increases total and triacsin C-resistant ACSL activity, co-local-
izes with endoplasmic reticulum and mitochondria, and increases fatty acid
uptake. A, ACSL activity was determined with 0.5, 1.0, and 2.0 g of McArdle-RH7777 cell
homogenate with or without 20 M triacsin C using palmitate as the substrate. Assay
conditions are described under “Experimental Procedures.” Data are means  S.D. from
a representative experiment performed in triplicate and repeated four times. B, McArdle-
RH7777 cells were fixed, permeabilized, and incubated with antibodies against FLAG,
Grp78 (endoplasmic reticulum marker), or VDAC (mitochondria marker). C, initial rates of
500 M [1-14C]oleic acid uptake were measured 24 h after infection and are shown as
means  S.D. from three dishes.
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The de novo synthesis of fatty acids canmake amajor contribution to
cellular fatty acid pools. To determine whether ACSL5 activates fatty
acids derived from de novo synthesis, we followed the incorporation of
2.5 mM [1-14C]acetic acid into cellular lipids. Although the metabolic
fate of acetic acid differed greatly from exogenous oleic acid, we
observed no differences between Ad-GFP- and Ad-ACSL5-infected
cells in themetabolism of acetic acid to any cellular lipid (Fig. 4B). Thus,
it appears that ACSL5 exclusively activates fatty acids from exogenous
sources and does not use fatty acids that are produced endogenously.
ACSL5 mRNA Abundance Changes in Response to Fasting and
Refeeding Support an Anabolic Role—Our in vitro data obtained from
overexpressing ACSL5 in McArdle-RH7777 cells suggest that ACSL5
partitions fatty acids to TAG synthesis. To gain insight into the in vivo
regulation of ACSL5, we measured changes in ACSL5 mRNA levels in
rats thatwere chow-fed, fasted for 48 h, or fasted for 48 h and refed a 70%
sucrose diet for 24 h. Abundance of ACSL5 mRNA decreased 54% in
response to a 48-h fast, but when rats were refed a high sucrose diet after
the fast, ACSL5 mRNA increased 26% above chow-fed levels (Fig. 5).
These in vivo changes in ACSL5 mRNA abundance further support the
in vitro data showing that ACSL5 functions in an anabolic capacity.
FIGURE 2. ACSL5 overexpression increases
[1-14C]oleic acid metabolism and partitioning
to cellular TAG at 500 M. McArdle-RH7777 cells
were labeled with various concentrations of
[1-14C]oleic acid from 24 to 27 h after infection
with Ad-GFP or Ad-ACSL5. Cells were harvested;
lipids were extracted, separated, and quantified;
and ASM was measured as described under
“Experimental Procedures.” Total fatty acid (Total
FA) metabolism includes cellular lipids, medium
TAG, and medium ASM. Data are means  S.D.
from a representative experiment performed in
triplicate and repeated three times. A, total
[1-14C]oleic acid metabolized; B, [1-14C]oleic acid
incorporation into cellular TAG; C, [1-14C]oleic acid
incorporation into medium TAG; D, [1-14C]oleic
acid incorporation into medium ASM. *, p  0.05.
FIGURE 3. In addition to TAG, Ad-ACSL5 increases incorporation of [1-14C]oleic acid
into DAG and confers resistance to triacsin C-mediated effects on fatty acid (FA)
metabolism. McArdle-RH7777 cells were labeled with 500 M [1-14C]oleic acid from
24 to 27 h after infection with Ad-GFP or Ad-ACSL5. Cells were harvested and lipids were
extracted, separated, and quantified as described under “Experimental Procedures.” A,
[1-14C]oleic acid incorporation into cellular lipids. Data are means  S.D. from a repre-
sentative experiment performed in triplicate and repeated at least three times. *, p  0.01
when compared with Ad-GFP-infected cells. B, incorporation of [1-14C]oleic acid into
cellular lipids, medium ASM, or total [1-14C]oleic acid metabolized in the presence of 10
M triacsin C or Me2SO as the carrier during the 3-h labeling period. Data are expressed
as a percentage of Ad-GFP- or Ad-ACSL5-infected cells incubated with 10 M Me2SO.
Data are means  S.D. from a representative experiment performed in triplicate and
repeated twice. PL, phospholipids; CE, cholesterol ester. *, p  0.01 when compared with
cells non-treated with triacsin C.
FIGURE 4. Ad-ACSL5 increases incorporation of [1-14C]oleic acid and [1,2,3-3H]glyc-
erol into TAG similarly and decreases [1,2,3-3H]glycerol into cellular phospholipids
(PL) but does not activate fatty acids (FA) derived from de novo synthesis. From 24 to
27 h after infection with Ad-GFP or Ad-ACSL5, McArdle-RH7777 cells were labeled with
500 M [1-14C]oleic acid and 250 M [1,2,3-3H]glycerol (A) or 2.5 mM [1-14C]acetate (B).
Cells were harvested and lipids were extracted, separated, and quantified as described
under “Experimental Procedures.” Values for [1-14C]oleic acid incorporation into TAG
and phospholipid in Ad-GFP-infected cells were 102  2.3 and 48.7  1.4 nmol/mg/3 h,
respectively; values for [1,2,3-3H]glycerol incorporation into TAG and phospholipid in
Ad-GFP-infected cells were 22.4  1.2 and 15.7  1.3 nmol/mg/3 h, respectively. Data are
means  S.D. from a representative experiment performed in triplicate and repeated
twice. *, p  0.01 when compared with Ad-GFP-infected cells.
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DISCUSSION
ACSL is the first enzyme required for fatty acid activation in almost
all known pathways of fatty acid metabolism. Given that five isoforms
have been identified in the ACSL family, as well as splice variants of
several of the isoforms, we suggest that there are distinct roles for the
individual isoforms and variants (26). Numerous studies have advanced
our understanding of the kinetic properties, tissue distribution and, to
some degree, intracellular localization of the ACSL isoforms, but they
have not directly shown that each isoform has a specific role in lipid
metabolism.
The current study was designed to directly test the effect of an indi-
vidual ACSL isoform, ACSL5, on the partitioning of fatty acids in the rat
hepatoma McArdle-RH7777 cell line. These cells are useful because
their fatty acid metabolism is similar to that of hepatocytes and, unlike
many hepatoma cell lines, McArdle-RH7777 cells secrete TAG in
lipoprotein-containing particles (27). We have shown that overexpres-
sion of ACSL5 increases fatty acid metabolism and primarily partitions
exogenous fatty acids to TAG that is destined for intracellular storage
but not secretion. This increase in TAG synthesis was only observed at
a high fatty acid concentration (500 M) that would be typical of pre-
prandial concentrations or a short term fast (23, 24). This suggests that
at lower fatty acid concentrations, sufficient endogenous ACSL activity
is present to metabolize exogenous fatty acids to acyl-CoAs. However,
when higher concentrations of fatty acids are present in the medium,
cellular ACSL activity may become limiting, thus hindering fatty acid
uptake. By overexpressing ACSL5 and increasing total cellular ACSL
activity 2-fold, intracellular fatty acid can be metabolized more rapidly,
and fatty acid uptake increases.
To date, most studies monitoring fatty acid uptake have focused on
plasmamembrane proteins such as fatty acid translocase/CD36 or fatty
acid transport proteins. Although these proteins undoubtedly enhance
fatty acid uptake, the exact mechanism is not clear. If overexpressing an
intracellular enzyme involved in activating fatty acids can increase the
flux of fatty acids through a given pathway, this would suggest that
uptake might be regulated by intracellular concentrations of fatty acids.
Pownall andHamilton (28) propose that increased intracellular conver-
sion of fatty acids to acyl-CoAs and their subsequent metabolism may
“pull” fatty acids into the cell by altering the fatty acid gradient across the
plasma membrane. In support of this hypothesis, 1-acyl-glycerol-3-
phosphate acyltransferase overexpression increases oleic acid uptake in
both adipocytes and myotubes (29). Although plasma membrane pro-
teins may catalyze part of the transport process, metabolism of the
incoming fatty acids may be more critical in regulation.
The 40% increase in fatty acid incorporation into TAG, without sub-
stantial increases in any other lipid besides DAG, gives credence to the
hypothesis that individual ACSL isoforms partition fatty acids toward
distinct pathways. Surprisingly, the increase in fatty acid incorporation
into cellular TAG did not coincide with increased TAG secretion. Since
medium TAG increased proportionately with increasing amounts of
fatty acid added to themedium, we can eliminate the possibility that the
capacity for very low density lipoprotein synthesis and secretion was
limiting. Therefore, fatty acids activated by ACSL5 may be destined for
an intracellular TAG pool with a low turnover rate. It is not known
whether DAG synthesized via enzymes located on mitochondria is
more or less prone to intracellular storage or secretion when compared
with endoplasmic reticulum-located enzymes, which include the termi-
nal enzyme in TAG synthesis, diacylglycerol acyltransferase. Overex-
pressing mitochondrial glycerol-3-phosphate acyltransferase increases
cellular TAG without increasing very low density lipoprotein secretion
in rat primary hepatocytes and thus argues that initiating the TAG
synthetic pathway in mitochondria predisposes the resulting TAG to
storage (30).
In agreement with the cell radiolabel studies, rat liver ACSL5 mRNA
decreased following a 48-h fast and increased upon refeeding a high
sucrose diet for 24 h. This pattern of ACSL5 message abundance sug-
gests that it encodes an enzyme involved in a TAG synthetic pathway.
Additional studies have also shown that ACSL5mRNA is regulated in a
manner concordant with an anabolic pathway. Hepatic ACSL5message
abundance increases in SREBP-1c transgenic mice (15) and in zinc-
deficient mice that have fatty livers (17). In addition, hepatic ACSL5
mRNA levels do not respond to peroxisomal proliferator-activated
receptor  agonists (14) and decrease in models with suppressed lipo-
genic gene expression such as SREBP cleavage-activating protein
knock-out mice (15), estrogen-related receptor knock-out mice (18),
and C57BL/6J obese ob/obmice following leptin administration (16). In
contrast to mRNA changes, rat hepatic mitochondrial ACSL5 protein
increases after a 48-h fast and decreases when rats are refed a high
sucrose diet (6). Discordant regulation of ACSL5mRNA and protein or
ACSL5 abundance on mitochondria and microsomes may occur.
Studies using triacsin C, an inhibitor of ACSL1, ACSL3, and ACSL4
but not ACSL5, have shownmore pronounced decreases in glycerolipid
synthesis than in fatty acid -oxidation (10, 25). Based on these data,
ACSL5 was hypothesized to activate fatty acids for -oxidation. There-
fore, it was surprising that Ad-ACSL5-infected cells did not substan-
tially alter ASM synthesis. It is possible that ACSL5 activates fatty acids
for both anabolic and catabolic pathways and that the supply of acyl-
CoAs derived from ACSL5 may be rate-limiting for TAG synthesis but
not for ASM synthesis. This rationale could explain the observed
increase in cellular TAG without a corresponding change in ASM syn-
thesis. To further explore this hypothesis, we inhibited ACSL1, ACSL3,
and ACSL4, the other known ACSL isoforms inMcArdle-RH7777 cells
with triacsin C. Interestingly, overexpression of ACSL5 conferred
resistance to the suppressive effects of triacsin C on cellular TAG syn-
thesis and the total amount of fatty acid metabolized. However, in
Ad-ACSL5-infected cells treated with triacsin C, ASM synthesis
decreased 21%. It should be noted that this decrease was attenuated
when compared with the 66% decrease in ASM synthesis in Ad-GFP-
infected cells treated with triacsin C. Thus, some of the acyl-CoAs
derived fromACSL5were likely used for ASM synthesis when the other
ACSL isoforms were inhibited. Although we hypothesize that ACSL
isoforms have unique roles in partitioning fatty acids, it is unlikely that
an individual isoform activates fatty acids exclusively for a given path-
way. More likely, a given ACSL isoformmay activate fatty acids that are
predominantly metabolized into a specific pathway. Some acyl-CoAs,
however, may “escape” and be metabolized by alternate pathways.
In contrast to the effects of triacsin C in primary hepatocytes and
FIGURE 5. Fasting decreases and refeeding increases hepatic ACSL5 mRNA abun-
dance in rats. Male Sprague-Dawley rats (130 g) were fed a chow diet, fasted for 48 h,
or refed a diet containing 70% sucrose for 24 h following a 48-h fast. Tissue harvesting,
RNA extraction, and quantitative real-time-PCR were carried out as described under
“Experimental Procedures.” Data are means  S.D. from four animals per group. *, p 
0.05 when compared with chow-fed rats.
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fibroblasts, in Ad-GFP-infected McArdle-RH7777 cells, triacsin C had
similar inhibitory effects on both TAG and ASM synthesis. Although
the triacsin C data further substantiate a major role for ACSL5 in TAG
synthesis, there are many caveats when using triacsin C. Many of the
ACSL isoforms have splice variants, most of which have not been tested
for triacsin C sensitivity. Very long chain acyl-CoA synthetases
(ACSVL) also possess some activity toward long chain fatty acids. Sim-
ilar to the ACSL splice variants, triacsin C sensitivity has not been tested
in many of the ACSVL isoforms. Additional research is needed to fur-
ther characterize other ACSL variants or ACSVL isoforms, their splice
variants, subcellular locations, and sensitivity to triacsin C.
In summary, adenoviral overexpression of ACSL5 in McArdle-
RH7777 cells increased fatty acid uptake into cells that were exposed to
fatty acid concentrations typical of a short term fast or preprandial state.
Although high fatty acid concentrations were needed to observe the
increase in fatty acid uptake, fatty acid incorporation into cellular TAG
was increased at all fatty acid concentrations tested.Despite the increase
in cellular TAG synthesis, Ad-ACSL5-infected cells did not increase the
amount of TAG secreted into the medium and did not use endog-
enously synthesized fatty acids. Taken together with changes in hepatic
mRNA levels in response to fasting and refeeding, we showed that, in
contrast to our original hypothesis, ACSL5 is predominantly involved in
synthetic rather than catabolic pathways. Although it is possible that the
function of overexpressed ACSL5 may differ from that of the endoge-
nous enzyme, these data suggest a unique role for ACSL5 in fatty acid
and TAG metabolism in McArdle-RH7777 cells.
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